Medications for Pediatric Ulcerative Colitis

3 results

  • Avsola

    (infliximab-axxq)
    Amgen Inc
    Usage: AVSOLA is indicated for reducing signs and symptoms, inducing and maintaining remission in moderately to severely active Crohn's disease (adult and pediatric), ulcerative colitis (adult and pediatric), and other conditions like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis.

  • Inflectra

    (infliximab-dyyb)
    Pfizer Laboratories Div Pfizer Inc
    Usage: INFLECTRA is indicated for treating moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults and pediatric patients aged 6 and older, especially after inadequate response to conventional therapies. It supports remission and symptom reduction.

  • Remicade

    (INFLIXIMAB)
    Janssen Biotech, Inc.
    Usage: REMICADE is indicated for treating moderate to severe Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults. It is also approved for pediatric Crohn's and ulcerative colitis. The drug helps induce and maintain remission and reduce symptoms.